BIBLIOGRAPHIC RECORD

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trial.

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
John Marsden; Michael Kelleher; Fiona Dunbar; Anna O Ermakova; Luke Mitcheson; Claire Roberts; James J Rucker; Gemma Scott; Ivan Saeger; Francesca Small; Mathieu Seynaeve
Source of metadata
PubMed
Year recorded
2025

Public identifiers and source

Open the source record

Reference

John Marsden; Michael Kelleher; Fiona Dunbar; Anna O Ermakova; Luke Mitcheson; Claire Roberts; James J Rucker; Gemma Scott; Ivan Saeger; Francesca Small; Mathieu Seynaeve. (2025). 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trial. https://pubmed.ncbi.nlm.nih.gov/41368982/

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-962b740eb35147cbcaa5ec3f959f8350/